申请人:Kester Robert Francis
公开号:US20120142705A1
公开(公告)日:2012-06-07
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
本文提供的是公式(I)的化合物及其药用盐,其中取代基如规范中所披露的那样。这些化合物及含有它们的药物组合物对于治疗代谢性疾病和紊乱,例如2型糖尿病等,具有用处。